Looking ahead, the momentum gained in 2024 must be maintained and amplified. By fostering a culture of belonging in the ...

My conclusion, having worked in various regions and corporate settings: don’t be loud. Be yourself. Be decent. Be ...

The Pharmaceutical Research and Manufacturers of America (PhRMA) trade body is donating $1 million to fund President-elect ...

Embedded heuristics and decision-making: In pharma, many decisions are guided by both data and heuristics (i.e., rules of ...

China's WuXi AppTec has agreed to sell a business unit serving the cell and gene therapy (CGT) sector to private equity firm ...

It was the day we’d all been waiting for. Rachel Reeves’ Autumn Budget felt like it had been on the horizon for a while. And it was great to see a commitment to the NHS, with an extra £22.6 ...

Private equity company Brookfield has reportedly moved closer to taking control of Grifols, after months of disruption at the Spanish pharma company. A report in Spanish newspaper El Confidencial ...

Shares in ophthalmology specialist Bausch + Lomb (B+L) have lost almost 10% of their value on a report that a joint takeover bid for the group is in trouble. The Financial Times has said that ...

Novartis has reached an agreement to take control of Kate Therapeutics, a developer of gene therapies for inherited neuromuscular diseases, including Duchenne muscular dystrophy (DMD). The ...

Kelun-Biotech has become the second drugmaker to bring a TROP2-directed antibody-drug conjugate to regulatory approval, getting a green light in China for sacituzumab tirumotecan (sac-TMT).

Field medical education before launch is linked to greater launch success, improving treatment adoption by up to 50%. New data also finds that biopharmas investing in pre-launch scientific ...

Access to a haematopoietic stem cell transplant (HSCT) in the US seems to depend on where a patient lives, and those in poorer areas may also have a higher risk of death from the procedure.